Effects of the support system combined with Chinese medicine on postoperative gastrointestinal recovery in patients with liver cancer.

IF 2.5 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Ting-Ting Luo, Meng-Yun Dong, Si Zhao, Xue-Zhen Zhai
{"title":"Effects of the support system combined with Chinese medicine on postoperative gastrointestinal recovery in patients with liver cancer.","authors":"Ting-Ting Luo, Meng-Yun Dong, Si Zhao, Xue-Zhen Zhai","doi":"10.4251/wjgo.v17.i8.105267","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The treatment of patients with liver cancer after surgery with the artificial liver support system combined with traditional Chinese medicine (TCM) for strengthening the body and removing blood stasis is a new idea.</p><p><strong>Aim: </strong>To analyze the post-surgical effect of the artificial liver support system with TCM in patients with liver cancer.</p><p><strong>Methods: </strong>Ninety-eight patients with liver cancer who underwent surgical treatment at the Fifth People's Hospital of Huai'an from January 2023-2024 were selected and divided into two groups (49 patients each) <i>via</i> random lottery method. Both groups underwent surgery. The control group received artificial liver support, and the observation group was additionally treated with TCM for strengthening the body and removing blood stasis. Gastrointestinal recovery, liver function, tumor marker levels, immune function, and safety were compared between both groups.</p><p><strong>Results: </strong>There were significant differences in the levels of indicators related to gastrointestinal recovery between the groups (<i>P</i> < 0.05). After treatment, the levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, and gamma-glutamyl transpeptidase in the observation group were lower, whereas the albumin level was higher (<i>P</i> < 0.05). After treatment, tumor marker levels in the observation group were relatively lower (<i>P</i> < 0.05). After treatment, compared to the control group, the CD4+ level in the observation group was higher and the CD8+ level was lower (<i>P</i> < 0.05). There was no significant difference in the incidence of adverse reactions between both groups (<i>P</i> > 0.05).</p><p><strong>Conclusion: </strong>Combining the artificial liver support system with TCM significantly improves liver and gastrointestinal functions, enhances immune responses, and reduces tumor marker levels with high safety, suggesting that it could be a promising approach for optimizing postoperative care and improving patient outcomes, potentially reducing complications and enhancing quality of life.</p>","PeriodicalId":23762,"journal":{"name":"World Journal of Gastrointestinal Oncology","volume":"17 8","pages":"105267"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362549/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4251/wjgo.v17.i8.105267","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The treatment of patients with liver cancer after surgery with the artificial liver support system combined with traditional Chinese medicine (TCM) for strengthening the body and removing blood stasis is a new idea.

Aim: To analyze the post-surgical effect of the artificial liver support system with TCM in patients with liver cancer.

Methods: Ninety-eight patients with liver cancer who underwent surgical treatment at the Fifth People's Hospital of Huai'an from January 2023-2024 were selected and divided into two groups (49 patients each) via random lottery method. Both groups underwent surgery. The control group received artificial liver support, and the observation group was additionally treated with TCM for strengthening the body and removing blood stasis. Gastrointestinal recovery, liver function, tumor marker levels, immune function, and safety were compared between both groups.

Results: There were significant differences in the levels of indicators related to gastrointestinal recovery between the groups (P < 0.05). After treatment, the levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, and gamma-glutamyl transpeptidase in the observation group were lower, whereas the albumin level was higher (P < 0.05). After treatment, tumor marker levels in the observation group were relatively lower (P < 0.05). After treatment, compared to the control group, the CD4+ level in the observation group was higher and the CD8+ level was lower (P < 0.05). There was no significant difference in the incidence of adverse reactions between both groups (P > 0.05).

Conclusion: Combining the artificial liver support system with TCM significantly improves liver and gastrointestinal functions, enhances immune responses, and reduces tumor marker levels with high safety, suggesting that it could be a promising approach for optimizing postoperative care and improving patient outcomes, potentially reducing complications and enhancing quality of life.

支持系统配合中药对肝癌患者术后胃肠功能恢复的影响。
背景:人工肝支持系统联合中药健体化瘀治疗肝癌术后患者是一种新的治疗思路。目的:分析中药辅助人工肝支持系统治疗肝癌术后疗效。方法:选择2023-2024年1月在淮安市第五人民医院行肝癌手术治疗的患者98例,采用随机抽签法分为两组,每组49例。两组都接受了手术。对照组患者给予人工肝支持,观察组患者在对照组基础上给予健体化瘀中药治疗。比较两组患者的胃肠恢复、肝功能、肿瘤标志物水平、免疫功能和安全性。结果:两组患者胃肠道恢复相关指标水平差异有统计学意义(P < 0.05)。治疗后,观察组患者丙氨酸转氨酶、天冬氨酸转氨酶、总胆红素、γ -谷氨酰转肽酶水平降低,白蛋白水平升高(P < 0.05)。治疗后,观察组患者肿瘤标志物水平较对照组明显降低(P < 0.05)。治疗后,观察组患者CD4+水平高于对照组,CD8+水平低于对照组(P < 0.05)。两组患者不良反应发生率比较,差异无统计学意义(P < 0.05)。结论:人工肝支持系统与中药联合应用可显著改善肝脏和胃肠功能,增强免疫反应,降低肿瘤标志物水平,安全性高,是优化术后护理,改善患者预后,减少并发症,提高生活质量的一种有前景的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Gastrointestinal Oncology
World Journal of Gastrointestinal Oncology Medicine-Gastroenterology
CiteScore
4.20
自引率
3.30%
发文量
1082
期刊介绍: The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信